Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Pathogen Reduced Cryoprecipitated Fibrinogen Complex (IFC) and Cryoprecipitated AHF Contain Von Willebrand Factor with Comparable Binding to Collagen and Support Shear-Induced Platelet Thrombus Formation

Subramanian Yegneswaran, Alessandro Zarpellon, Jennifer N Orje, Michelle Gatmaitan, Nina Mufti, Laurence Corash, Zaverio M Ruggeri

Blood (2023) 142 (Supplement 1): 4039.

https://doi.org/10.1182/blood-2023-187124

Published: 2023

Journal Articles

Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia

Xiao-Yan Zhao, PhD, Subramanian Yegneswaran, PhD, Maxine Bauzon, Derek Sim, Chandra Patel, PhD, Doug Schneider, Kirk McLean, Ying Zhu, MD, Xiaoqiao Jiang, Vince Evans, Jian-Ming Gu, PhD, Inge Ivens, PhD, Jun Xu, PhD, Peter Wolfgang Bringmann, PhD, Katalin Kauser, Charles Esmon, PhD

Blood (2016) 128 (22): 80.

https://doi.org/10.1182/blood.V128.22.80.80

Published: 2016

Journal Articles

Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data

Hiroshi Deguchi, Yajnavalka Banerjee, Sunia Trauger, Gary Siuzdak, Ewa Kalisiak, José A. Fernández, Linh Hoang, Minerva Tran, Subramanian Yegneswaran, Darlene J. Elias, John H. Griffin

Blood (2015) 126 (13): 1595–1600.

https://doi.org/10.1182/blood-2015-03-636761

Published: 2015

Includes: Supplemental data

Journal Articles

Acylcarnitines Are Novel Anticoagulant Lipids That Target Factor Xa and That Are Reduced in Plasma of Venous Thrombosis Patients Based on Untargeted and Targeted Metabolomics

Hiroshi Deguchi, MD PhD, Yajnavalka Banerjee, PhD, Gary Siuzdak, PhD, Sunia Trauger, PhD, Ewa Kalisiak, PhD, Jose A. Fernandez, MD PhD, Linh Hoang, Minerva Tran, Subramanian Yegneswaran, PhD, Darlene J Elias, MD, John H. Griffin, PhD

Blood (2014) 124 (21): 2797.

https://doi.org/10.1182/blood.V124.21.2797.2797

Published: 2014

Journal Articles

Site-Directed Pegylation of BDD FVIII (BAY 94-9027) Does Not Alter the Ability of the Molecule to Generate Thrombin, Activate Factor X or Become Inactivated By Activated Protein C

Subramanian Yegneswaran, PhD, Xiaoqiao Jiang, BS, Pooja Yesantharao, Ji-Yun Kim, PhD, Lilley Leong, PhD MS, Derek S Sim, PhD, Chandra Patel, PhD, Katalin Zsofia Kauser, PhD MD DSc

Blood (2014) 124 (21): 1492.

https://doi.org/10.1182/blood.V124.21.1492.1492

Published: 2014

Journal Articles

Plasma High Density Lipoprotein and Anticoagulant Response to Activated Protein C (APC) and Protein S

Jose A. Fernandez, MD, PhD, Hiroshi Deguchi, MD, PhD, Natalie M Pecheniuk, Ph.D., Subramanian Yegneswaran, PhD, Carole L Banka, Ph. D., John H. Griffin, PhD

Blood (2011) 118 (21): 2249.

https://doi.org/10.1182/blood.V118.21.2249.2249

Published: 2011

Journal Articles

Lyso-Sulfatide Binds Factor Xa and Potently Inhibits Thrombin Generation.

Subramanian Yegneswaran, PhD, Yajnavalka Banerjee, PhD, Jose A. Fernandez, MD, PhD, Hiroshi Deguchi, MD, PhD, John H. Griffin, PhD

Blood (2010) 116 (21): 1130.

https://doi.org/10.1182/blood.V116.21.1130.1130

Published: 2010

Journal Articles

Another Look at Thrombin-GPIba Interaction in Solution Phaseα

Subramanian Yegneswaran, PhD, James R. Roberts, Richard A. McClintock, Zaverio M. Ruggeri, MD

Blood (2005) 106 (11): 1646.

https://doi.org/10.1182/blood.V106.11.1646.1646

Published: 2005

Journal Articles

Exosite-Specific Inhibition of Thrombin Using Photo-Crosslinked Fluorescent Reporter Peptides.

Subramanian Yegneswaran, PhD, Theresa Tiefenbrunn, Jose’ A. Fernandez, MD, PhD, Philip E. Dawson, PhD

Blood (2005) 106 (11): 1954.

https://doi.org/10.1182/blood.V106.11.1954.1954

Published: 2005

Journal Articles

Prothrombin Residues 473 to 487 Contribute To Factor Va Binding in the Prothrombinase Complex.

Subramanian Yegneswaran, Ph.D., Rolf M. Mesters, M.D., Jose A. Fernandez, M.D. Ph.D., John H. Griffin, Ph.D.

Blood (2004) 104 (11): 1720.

https://doi.org/10.1182/blood.V104.11.1720.1720

Published: 2004

Journal Articles

Activated protein C variants with normal cytoprotective but reduced anticoagulant activity

Laurent O. Mosnier, Andrew J. Gale, Subramanian Yegneswaran, John H. Griffin

Blood (2004) 104 (6): 1740–1744.

https://doi.org/10.1182/blood-2004-01-0110

Published: 2004

NARROW

Pathogen Reduced Cryoprecipitated Fibrinogen Complex (IFC) and Cryoprecipitated AHF Contain Von Willebrand Factor with Comparable Binding to Collagen and Support Shear-Induced Platelet Thrombus Formation

Targeted Inhibition of Activated Protein C Anticoagulant Activity By Monoclonal Antibody HAPC1573 for Treatment of Hemophilia

Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data

Acylcarnitines Are Novel Anticoagulant Lipids That Target Factor Xa and That Are Reduced in Plasma of Venous Thrombosis Patients Based on Untargeted and Targeted Metabolomics

Site-Directed Pegylation of BDD FVIII (BAY 94-9027) Does Not Alter the Ability of the Molecule to Generate Thrombin, Activate Factor X or Become Inactivated By Activated Protein C

Plasma High Density Lipoprotein and Anticoagulant Response to Activated Protein C (APC) and Protein S

Lyso-Sulfatide Binds Factor Xa and Potently Inhibits Thrombin Generation.

Another Look at Thrombin-GPIba Interaction in Solution Phaseα

Exosite-Specific Inhibition of Thrombin Using Photo-Crosslinked Fluorescent Reporter Peptides.

Prothrombin Residues 473 to 487 Contribute To Factor Va Binding in the Prothrombinase Complex.

Activated protein C variants with normal cytoprotective but reduced anticoagulant activity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only